News

A study by the IIBB, among the eight finalists for the Vanguardia Science Award

The article on soluble AXL as novel early biomarker of pancreatic cancer (eBioMedicine 2022), led by Pilar Navarro and Pablo Garcia de Frutos, has been selected as a finalist for the Vanguard Scien

Read More

SYMPOSIUM PROFESSIONAL OPPORTUNITIES WITH A GENDER PERSPECTIVE WITHIN BIOMEDICAL RESEARCH

Join the IIBB-CSIC in celebrating the International Day of Women and Girls in Science!

Read More

A NEW STUDY UNCOVERS A FUNCTIONAL RELATIONSHIP BETWEEN METHIONINE AND SPHINGOLIPID METABOLISM RELEVANT IN THE DEVELOPMENT OF CHRONIC LIVER DISEASES

The liver plays a major role in the metabolism of methionine and disruption of this pathway is associated with chronic liver disease.

Read More

The accumulation of lipid droplets in microglia contributes to the pathological processes of ischemic stroke

More than 12 million people suffer a stroke each year and the neurological consequences are worse in elderly patient, which are also the most vulnerable.

Read More

The IIBB is a beneficiary partner of the HORIZON-HLTH-2022- EU Project HALT-RONIN (Halt-Chronic Inflammation).

The HORIZON-HLTH-2022-STAYHLTH-02/101095679 project entitled: “Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH transition to inform early prevention an

Read More

Found a genetic mechanism involved in a multisystem inflammatory syndrome that aggravates Covid-19 in some children

A team of researchers, including Dr. Anna Planas from the IIBB-CSIC, has found a genetic mechanism involved in a type of exaggerated immune reaction that aggravates covid-19 in some children.

Read More

Nanoparticles for gene therapy directed to cellular targets in the brain

  • A collaborative research work patents a gene therapy procedure based on liposomal nanoparticles, successfully tested in rodents, capable of delivering therapeutic oligonucleotides directly to
Read More

Pages